|
Decades of chemical pesticide use have left behind a toxic legacy. But a safer alternative is gaining ground – and Med-X is leading the charge.
Med-X's Nature-Cide product line offers plant-based pest control solutions proven to be just as effective as legacy chemical brands – without the health and environmental side effects. Their formulas are designed to be safer when used as directed and have outperformed chemical options in third-party lab tests in some use cases.
- Safe for use around children and pets when used as directed.
- Less impact on beneficials and pollinators like bees when used as directed.
- Available today through ecommerce leaders Walmart, Amazon, and Kroger as well as extensive commercial distribution partnerships.
- Professional-grade use in pest control, hospitality, and public health.
This is no longer just a niche preference – it's a macro shift. Consumers, businesses, and regulators are demanding cleaner options. That's why Med-X has made it their mission to meet the market where it's going, not where it's been.
With over $6.4M in revenue in the past four years and growing adoption across multiple channels, Med-X is poised to be the go-to brand in sustainable pest management. And now, they're preparing for a public market move – with a planned Nasdaq listing (MXRX) in sight.
Today, investors can still access shares at $4.00 through a Regulation A+ round. This is your chance to align with one of the few companies commercializing effective, eco-conscious alternatives at scale.
Med-X's timing couldn't be better – pesticide bans are increasing, ESG investing is rising, and retail channels are wide open for clean-label innovation.
If you're looking for a company solving a real problem with a trusted solution and strong tailwinds behind it, this is the moment to act.
Learn more about Med-X's investment opportunity >>
|